Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Mar 2022 10:46

RNS Number : 4450F
4d Pharma PLC
21 March 2022
 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

4D PHARMA PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify) iii:

 

3. Details of person subject to the notification obligation iv

Name

Steven Oliveira and connected parties

City and country of registered office (if applicable)

225 Via Palacio

Palm Beach Gardens

FL 33418

USA

4. Full name of shareholder(s) (if different from 3.) v

Name

South Ocean Capital Management, LLC

South Ocean Capital, LLC

Nemean Asset Management, LLC

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached vi:

18 March 2022

6. Date on which issuer notified (DD/MM/YYYY):

18 March 2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

3.84

0

3.84

6,918,432

Position of previous notification (if

applicable)

4.94

0

4.94

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary Shares of £0.0025 each

 

6,918,432

0

3.84

0

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

 

 

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

South Ocean Capital Management, LLC

0.22

 

0.22

South Ocean Capital, LLC

0.34

 

0.34

Nemean Asset Management LLC

3.28

 

3.28

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional information xvi

 

     

 

Place of completion

FL, USA

Date of completion

21 March 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFSIVIILFIF
Date   Source Headline
2nd Aug 20217:00 amRNSTwo MRx0518 presentations accepted for ESMO 2021
29th Jul 20217:00 amRNS$30 Million Credit Facility with Oxford Finance
26th Jul 20211:00 pmRNSPassing of Chief Financial Officer John Beck
6th Jul 20217:00 amRNSPublication - LBP improves activity of CAR-T
29th Jun 20217:00 amRNSLadenburg Thalmann Healthcare Conference
22nd Jun 20217:00 amRNSConference presentation on LBP Manufacturing’
4th Jun 20217:00 amRNSAsthma trial Part A enrolment and program update
1st Jun 20218:52 amRNSTotal Voting Rights
24th May 202110:48 amRNSResult of AGM
24th May 20217:00 amRNSUpdate on Data for Phase II Study of Blautix
17th May 20217:00 amRNSPresentation of Blautix IBS Phase II at DDW 2021
19th Apr 20217:00 amRNSCollaboration with Parkinson’s UK
16th Apr 20217:00 amRNSDirectors’ Subscription for new Ordinary Shares
15th Apr 20215:00 pmRNSAnnual Financial Report
15th Apr 20217:00 amRNSParticipation in Jefferies Therapeutics Summit
12th Apr 20212:26 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHow to Convert AIM Ordinary Shares into Nasdaq ADS
1st Apr 20217:00 amRNSFinal Results
26th Mar 20213:21 pmRNSHolding(s) in Company
25th Mar 202112:08 pmRNSHolding(s) in Company
25th Mar 20218:00 amRNSHolding(s) in Company
22nd Mar 20217:00 amRNSCompletion of Merger
18th Mar 20211:25 pmRNSResult of Meeting
17th Mar 20211:00 pmRNS4D Pharma Announces Private Placement
3rd Mar 20217:00 amRNSInvestor conference participation
1st Mar 20215:49 pmRNSExercise of Options and Total Voting Rights
1st Mar 20217:02 amRNSJohn Beck Appointed as Chief Financial Officer
1st Mar 20217:00 amRNSAppoints Paul Maier to the Board as NED
26th Feb 202112:52 pmRNSHolding(s) in Company
26th Feb 20217:02 amRNSPosting of Circular
26th Feb 20217:00 amRNSU.S. SEC Declares Registration Statement Effective
16th Feb 20217:00 amRNSMicrobiome Leaders Panel Event
8th Feb 20217:45 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSOncology Clinical Collaboration
4th Feb 20212:55 pmRNSHolding(s) in Company
3rd Feb 20217:00 amRNSOncology Program Update
1st Feb 20212:10 pmRNSTotal Voting Rights
27th Jan 20217:00 amRNSHolding(s) in Company
25th Jan 20216:01 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSConference participation
30th Dec 20208:32 amRNSHolding(s) in Company
29th Dec 20205:17 pmRNSHolding(s) in Company
29th Dec 20202:24 pmRNSHolding(s) in Company
22nd Dec 20202:31 pmRNSHolding(s) in Company
18th Dec 20208:53 amRNSJoins MJFF-sponsored Parkinson’s study consortium
27th Nov 20203:42 pmRNSHolding(s) in Company
26th Nov 20207:09 amRNSRegistration Statement filed with SEC
23rd Nov 20207:00 amRNSLongevity extends Business Combination deadline
12th Nov 202012:18 pmRNSHolding(s) in Company
9th Nov 20206:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.